Synthetopes Inc recalls Sn-d, l-Exametazime (Sn-d,l-HMPAO), Not for Direct Injection, Store Below 25 C, Synthetopes, Inc.
- Recall date
- May 28, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1403-2019
- FDA classification
- Class II
- Brand / firm
- Synthetopes Inc
- Sold / distributed
- Nationwide.
Why it was recalled
Lack of Processing Controls.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sn-d, l-Exametazime (Sn-d,l-HMPAO), Not for Direct Injection, Store Below 25 C, Synthetopes, Inc.
Get recall alerts
Free email alert whenever Synthetopes Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Synthetopes Inc